CLINICAL_TRIALS
research
· 2017-05-30
Clinical Trial Update: Examining Physiology and Brain Function in People With the Fragile X Premutation
Summary
This clinical trial update describes a completed study led by UC Davis that examined physiology and brain function in people with the Fragile X Premutation.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of California, Davis | Conditions: Fragile X Premutation | Status: COMPLETED